Figure 1
Figure 1. The design of the phase 1 dose-escalation study in patients with RRMM. dex, dexamethasone; POM, pomalidomide; QD, one a day; wk, week.

The design of the phase 1 dose-escalation study in patients with RRMM. dex, dexamethasone; POM, pomalidomide; QD, one a day; wk, week.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal